Miri Halperin Wernli
Follow
Get notifications in MyBN when activity occurs.
Miri Halperin Wernli
Strategic Advisor / Creso Pharma
Dr Miri Halperin Wernli is a senior pharmaceutical and biomedical executive with over 25 years of strategic and operational leadership in the biopharmaceutical industry and a deep understanding of drug and product development.
Dr Halperin Wernli has held worldwide senior leadership positions in product development, R&D and strategic marketing throughout Switzerland and in the US (Merck, Sharp and Dohme, Roche and Actelion pharmaceuticals).
Dr Halperin Wernli is an experienced pharmaceutical leader with skills and broad expertise in drug development, regulatory affairs, project & portfolio management, development finance & controlling, corporate strategy and governance. Her extensive pharmaceutical industry and biomed research and development experience covers the full spectrum of areas and activities from pre-clinical to clinical development & strategy, to drug registration and launch, across several therapeutic areas.
Dr Halperin Wernli has held worldwide senior leadership positions in product development, R&D and strategic marketing throughout Switzerland and in the US (Merck, Sharp and Dohme, Roche and Actelion pharmaceuticals).
Dr Halperin Wernli is an experienced pharmaceutical leader with skills and broad expertise in drug development, regulatory affairs, project & portfolio management, development finance & controlling, corporate strategy and governance. Her extensive pharmaceutical industry and biomed research and development experience covers the full spectrum of areas and activities from pre-clinical to clinical development & strategy, to drug registration and launch, across several therapeutic areas.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 815th | Creso Pharma | 1% | -27% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Creso Pharma | $144.7m |
198 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEW ROLE: Strategic Advisor, Creso Pharma | 06 Sep 2021 |
| NEW ROLE: Non-Executive Director, Creso Pharma | 06 Sep 2021 |
| REMUNERATION UPDATE: Co-Founder, Group Chief Executive, Executive Director, Head of Technology, Innovation & Distribution, Creso Pharma | 03 Nov 2020 |
